# AlloSource – FDA Inspection, Mar 30, 2023

Source: https://www.keypedia.com/records/fda_inspections/allosource/9feeb28f-e5dc-4eb3-8401-23c3664c6f22
Source feed: FDA_Inspections

> FDA inspection 1201259 of AlloSource, March 30, 2023. Classification: No Action Indicated (NAI). 2 citations under 21 CFR part 1271. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201259
- Company Name: AlloSource
- Inspection Date: 2023-03-30
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1333098 - 2026-08-28](https://www.keypedia.com/records/fda_inspections/allosource/2a5be685-c931-464a-b381-88ded2053088)
- FDA Inspection 1175639 - 2022-07-27
- [FDA Inspection 1074854 - 2018-12-18](https://www.keypedia.com/records/fda_inspections/allosource/bb193ac1-e1f8-4240-b903-129e24667479)
- [FDA Inspection 1010063 - 2017-02-09](https://www.keypedia.com/records/fda_inspections/allosource/be4789ed-58a8-46bc-953e-642b88c9f776)
- FDA Inspection 929703 - 2015-06-11

## Related Officers

- [Erma Zaimova](https://www.keypedia.com/people/erma-zaimova/87da23ad-48bb-4096-9d8a-e8511c6b5c98)
- [Issuing Officer](https://www.keypedia.com/people/shelley-h-beausoleil/1212116b-e24d-4bbc-a27a-5c16334d573e)

Company: https://www.keypedia.com/companies/allosource/561511d2-2b9d-4a29-9565-deccb49a8455

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
